Johnson & Johnson’s JNJ third-quarter 2023 earnings came in at $2.66 per share, which beat the Zacks Consensus Estimate of $2.52. Earnings rose 19.3% from the year-ago period. Adjusted earnings ...
Johnson & Johnson’s JNJ third-quarter 2024 earnings came in at $2.42 per share, which beat the Zacks Consensus Estimate of $2.22. Earnings declined 9% from the year-ago period. Adjusted earnings ...
Zacks.com on MSN
J&J's Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance
Johnson & Johnson’s JNJ fourth-quarter 2024 earnings came in at $2.04 per share, which beat the Zacks Consensus Estimate of ...
Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 2024 ...
(Reuters) -Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results